110 related articles for article (PubMed ID: 3586326)
1. [The neuromuscular blocking activity of isepamicin sulfate (HAPA-B) compared with other aminoglycoside antibiotics].
Shinoda Y; Mochizuki D; Hokonohara T; Takayanagi N
Jpn J Antibiot; 1987 Jan; 40(1):136-44. PubMed ID: 3586326
[TBL] [Abstract][Full Text] [Related]
2. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
Shibata K; Mita I; Shinoda Y; Nakano U; Kinoshita H; Noguchi M; Uzawa T; Sohmiya Y; Takayanagi N
Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):188-201. PubMed ID: 3586328
[TBL] [Abstract][Full Text] [Related]
4. [Neuromuscular blocking properties of arbekacin, astromicin, isepamicin and netilmicin in the rabbit].
Endo K
Jpn J Antibiot; 1999 Aug; 52(8):554-61. PubMed ID: 10587880
[TBL] [Abstract][Full Text] [Related]
5. [Toxicological studies on isepamicin (HAPA-B). II. Intramuscular subacute toxicity test in the rat].
Morino T; Endo H; Shiraiwa K; Sano K; Miura M; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3179-200. PubMed ID: 3560436
[TBL] [Abstract][Full Text] [Related]
6. [Toxicological studies on isepamicin (HAPA-B). I. Acute toxicity test in the mouse, rat and dog].
Morino T; Sano K; Hara H; Motoyama K; Iizuka K; Hara T; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3164-78. PubMed ID: 3560435
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular blocking activity of aminoglycoside antibiotics.
Paradelis AG; Triantaphyllidis C; Giala MM
Methods Find Exp Clin Pharmacol; 1980 Feb; 2(1):45-51. PubMed ID: 6121961
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular blocking effects of the aminoglycoside antibiotics arbekacin, astromicin, isepamicin and netilmicin on the diaphragm and limb muscles in the rabbit.
Liu M; Kato M; Hashimoto Y
Pharmacology; 2001; 63(3):142-6. PubMed ID: 11598419
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycoside antibiotics: interaction with trimethaphan at the neuromuscular junctions.
Paradelis AG; Crassaris LG; Karachalios DN; Triantaphyllidis CJ
Drugs Exp Clin Res; 1987; 13(4):233-6. PubMed ID: 3622253
[TBL] [Abstract][Full Text] [Related]
10. The comparative neuromuscular blocking effects of some aminoglycoside antibiotics.
Rutten JM; Booij LH; Rutten CL; Crul JF
Acta Anaesthesiol Belg; 1980; 31(4):293-306. PubMed ID: 6111886
[TBL] [Abstract][Full Text] [Related]
11. Effects of aminoglycoside antibiotics on the neuromuscular junction: Part I.
Yamada S; Kuno Y; Iwanaga H
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):130-8. PubMed ID: 3699939
[TBL] [Abstract][Full Text] [Related]
12. The neuromuscular blocking activity of a new aminoglycoside antibiotic netilmicin sulphate (SCH 20569).
Albiero L; Ongini E; Parravicini L
Eur J Pharmacol; 1978 Jul; 50(1):1-7. PubMed ID: 679972
[TBL] [Abstract][Full Text] [Related]
13. [Toxicological studies on isepamicin (HAPA-B). IV. Intramuscular subacute toxicity test in the dog].
Nakanishi D; Sano K; Iizuka K; Miura M; Morino T; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3201-44. PubMed ID: 3560437
[TBL] [Abstract][Full Text] [Related]
14. The neuromuscular blocking activity of aminodeoxykanamycin as compared with that of other aminoglycoside antibiotics.
Paradelis AG; Triantaphyllidis C; Markomichelakis JM; Logaras G
Arzneimittelforschung; 1977; 27(1):141-3. PubMed ID: 576814
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blocking effects of aminoglycoside antibiotics on fast- and slow-contracting muscles of the cat.
Adams HR; Mathew BP; Teske RH; Mercer HD
Anesth Analg; 1976; 55(4):500-7. PubMed ID: 945953
[TBL] [Abstract][Full Text] [Related]
16. [Neuromuscular inhibition of new aminoglycoside antibiotics].
Orts A; Marti JL; Baltar I; Esplugues J
Ann Anesthesiol Fr; 1979; 20(1):25-30. PubMed ID: 38693
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). IV. Intramuscular, intravenous and drip intravenous administration of HAPA-B in dogs].
Serizawa K; Shirai M; Endo S; Suzuki T; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):220-31. PubMed ID: 3586331
[TBL] [Abstract][Full Text] [Related]
18. [Toxicological studies on isepamicin (HAPA-B). VII. Chronic intramuscular test in the rat].
Fujii H; Shiraiwa K; Miura M; Morino T; Matsumoto K; Yamamoto H
Jpn J Antibiot; 1986 Dec; 39(12):3245-82. PubMed ID: 3560438
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the neuromuscular blocking activity of three new aminoglycoside antibiotics in rats.
Renna G; Siro-Brigiani G; Cuomo V
Toxicol Lett; 1981 Oct; 9(2):107-12. PubMed ID: 7302981
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). III. Intramuscular, intravenous and drip intravenous administration of HAPA-B in rabbits].
Suzuki T; Somiya Y; Shirai M; Sakai A; Iwasaki M; Morishita M
Jpn J Antibiot; 1987 Jan; 40(1):208-19. PubMed ID: 3586330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
